Novel Mutations Associated with Clofazimine Resistance in Mycobacterium Abscessus.

Yuanyuan Chen,Jiazhen Chen,Shuo Zhang,Wanliang Shi,Wenhong Zhang,Min Zhu,Ying Zhang
DOI: https://doi.org/10.1128/aac.00544-18
IF: 5.938
2018-01-01
Antimicrobial Agents and Chemotherapy
Abstract:ABSTRACT Mycobacterium abscessus is a major nontuberculous mycobacterial (NTM) pathogen and is responsible for about 80% of all pulmonary infections caused by rapidly growing mycobacteria. Clofazimine is an effective drug active against M. abscessus , but the mechanism of resistance to clofazimine in M. abscessus is unknown. To investigate the molecular basis of clofazimine resistance in M. abscessus , we isolated 29 M. abscessus mutants resistant to clofazimine and subjected them to whole-genome sequencing to identify possible mutations associated with clofazimine resistance. We found that mutations in the MAB_2299c gene (which encodes a possible transcriptional regulatory protein), MAB_1483, and MAB_0540 are most commonly associated with clofazimine resistance. In addition, mutations in MAB_0416c, MAB_4099c, MAB_2613, MAB_0409, and MAB_1426 were also associated with clofazimine resistance but less frequently. Two identical mutations which are likely to be polymorphisms unrelated to clofazimine resistance were found in MAB_4605c and MAB_4323 in 13 mutants. We conclude that mutations in MAB_2299c, MAB_1483, and MAB_0540 are the major mechanisms of clofazimine resistance in M. abscessus . Future studies are needed to address the role of the identified mutations in clofazimine resistance in M. abscessus . Our findings have implications for understanding mechanisms of resistance to clofazimine and for rapid detection of clofazimine resistance in this organism.
What problem does this paper attempt to address?